EyePoint Pharmaceuticals Inc.
EYPT | NASDAQ
$4.10
+$0.08 (+1.99%)
Sep 22, 2026, 1:20 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 101.82M | 99.7M | 281.26M | 95.63M | 178.59M | 44.91M |
Short-Term Investments | 204.27M | 271.21M | 49.79M | 48.93M | 32.97M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 15.12M | 5.98M | 150K | 150K | 150K | 150K |
Receivables | 651K | 607K | 805K | 15.5M | 18.35M | 9.45M |
Inventory | 1.81M | 2.31M | 3.91M | 2.89M | 3.62M | 5.34M |
Other Current Assets | 20.11M | 1.41M | 1.01M | 782K | 517K | n/a |
Total Current Assets | 328.66M | 383.31M | 344.8M | 172.81M | 237.75M | 63.12M |
Property-Plant & Equipment | 20.22M | 29.18M | 10.23M | 7.4M | 2.73M | 3.24M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | 22.75M | 25.21M |
Total Long-Term Assets | 35.34M | 35.16M | 10.38M | 7.55M | 25.63M | 28.6M |
Total Assets | 364M | 418.47M | 355.18M | 180.36M | 263.37M | 91.72M |
Account Payables | 10.49M | 11.72M | 6.5M | 5.92M | 7.39M | 4.81M |
Deferred Revenue | n/a | 17.78M | 38.59M | 1.21M | 1.07M | 945K |
Short-Term Debt | n/a | n/a | n/a | 10.48M | n/a | n/a |
Other Current Liabilities | 180K | 13.27M | 13.28M | 9.52M | 7.32M | 5.69M |
Total Current Liabilities | 37.02M | 49.05M | 63.26M | 34.54M | 23.66M | 14.89M |
Long-Term Debt | n/a | n/a | n/a | 29.31M | 36.56M | 37.98M |
Other Long-Term Liabilities | 87K | 205K | n/a | 600K | 2.35M | 2.37M |
Total Long-Term Liabilities | 20.86M | 32.92M | 25.6M | 49.45M | 55.33M | 58.29M |
Total Liabilities | 57.88M | 81.96M | 88.86M | 83.99M | 78.99M | 73.18M |
Total Debt | 22.79M | 21.86M | 4.91M | 46.35M | 39.2M | 40.99M |
Book Value | 306.11M | 336.5M | 266.32M | 96.37M | 184.38M | 18.54M |
Book Value Per Share | 4.18 | 5.98 | 6.85 | 2.58 | 6.41 | 1.44 |
Common Stock | 83K | 68K | 49K | 34K | 34K | 18K |
Retained Earnings | -1.1B | -873.02M | -742.15M | -671.35M | -569.1M | -510.68M |
Comprehensive Income | 961K | 1.03M | 864K | 786K | 841K | 841K |
Shareholders Equity | 306.11M | 336.5M | 266.32M | 96.37M | 184.38M | 18.54M |
Total Investments | 204.27M | 271.21M | 49.79M | 48.93M | 32.97M | n/a |
Add to Watchlist
Select watchlists to add or remove EYPT